Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Sep;68(3):819–822. doi: 10.1172/JCI110320

Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.

G Tolis, A Mehta, A M Comaru-Schally, A V Schally
PMCID: PMC370866  PMID: 6456277

Abstract

Four male transsexual subjects were given a superactive luteinizing hormone-releasing hormone (LHRH) analogue, D-tryptophan-6-LHRH at daily doses of 100 micrograms for 3--6 mo. A decrease in beard growth, acne, and erectile potency was noted; the latter was documented objectively with the recordings of nocturnal penile tumescence episodes. Plasma testosterone and dihydrotestosterone levels fell to castrate values; basal prolactin and luteinizing hormone levels showed a small decline, whereas the acutely releasable luteinizing hormone was significantly suppressed. A rise of plasma testosterone from castrate to normal levels was demonstrable with the use of human chorionic gonadotropin. Discontinuation of treatment led to a normalization of erectile potency and plasma testosterone. The suppression of Leydig cell function by D-tryptophan-6-LHRH might have wide application in reproductive biology and in endocrine-dependent neoplasia (where it could replace surgical castration).

Full text

PDF
819

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert A., Rosemberg E., Ross G. T., Paulsen C. A., Ryan R. J. Report of the National Pituitary Agency collaborative study on the radioimmunoassay of FSH and LH. J Clin Endocrinol Metab. 1968 Aug;28(8):1214–1219. doi: 10.1210/jcem-28-8-1214. [DOI] [PubMed] [Google Scholar]
  2. Auclair C., Kelly P. A., Labrie F., Coy D. H., Schally A. V. Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin. Biochem Biophys Res Commun. 1977 Jun 6;76(3):855–862. doi: 10.1016/0006-291x(77)91579-0. [DOI] [PubMed] [Google Scholar]
  3. Bélanger A., Caron S., Picard V. Simultaneous radioimmunoassay of progestins, androgens and estrogens in rat testis. J Steroid Biochem. 1980 Feb;13(2):185–190. doi: 10.1016/0022-4731(80)90190-9. [DOI] [PubMed] [Google Scholar]
  4. Carter J. N., Tyson J. E., Tolis G., Van Vliet S., Faiman C., Friesen H. G. Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med. 1978 Oct 19;299(16):847–852. doi: 10.1056/NEJM197810192991602. [DOI] [PubMed] [Google Scholar]
  5. Crowley W. F., Jr, Comite F., Vale W., Rivier J., Loriaux D. L., Cutler G. B., Jr Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab. 1981 Feb;52(2):370–372. doi: 10.1210/jcem-52-2-370. [DOI] [PubMed] [Google Scholar]
  6. Heber D., Swerdloff R. S. Male contraception; synergism of gonadotropin-releasing hormone analog and testosterone in suppressing gonadotropin. Science. 1980 Aug 22;209(4459):936–938. doi: 10.1126/science.6773142. [DOI] [PubMed] [Google Scholar]
  7. Hsueh A. J., Erickson G. F. Extra-pituitary inhibition of testicular function by luteinising hormone releasing hormone. Nature. 1979 Sep 6;281(5726):66–67. doi: 10.1038/281066a0. [DOI] [PubMed] [Google Scholar]
  8. Hwang P., Guyda H., Friesen H. A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A. 1971 Aug;68(8):1902–1906. doi: 10.1073/pnas.68.8.1902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jaramillo Jaramillo C., Pérez-Infante V., López Maciá A., Salgado A. C., Coy D. H., Schally A. V. Serum LH, FSH and testosterone response to the administration of a new LH-RH analog, D-Trp6-LH-RH, in normal men. Int J Fertil. 1977;22(2):77–84. [PMC free article] [PubMed] [Google Scholar]
  10. Mikhail G., Wu C. H., Ferin M., Vande Wiele R. L. Radioimmunoassay of plasma estrone and estradiol. Steroids. 1970 Mar;15(3):333–352. doi: 10.1016/s0039-128x(70)80053-8. [DOI] [PubMed] [Google Scholar]
  11. Smith R., Donald R. A., Espiner E. A., Stronach S. The effects of prolonged administration of D-Ser (TBU)6-LH-RH-EA10 (HOE 766) in subjects with hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 1979 Nov;11(5):553–559. doi: 10.1111/j.1365-2265.1979.tb03108.x. [DOI] [PubMed] [Google Scholar]
  12. Spark R. F., White R. A., Connolly P. B. Impotence is not always psychogenic. Newer insights into hypothalamic-pituitary-gonadal dysfunction. JAMA. 1980 Feb 22;243(8):750–755. [PubMed] [Google Scholar]
  13. Tharandt L., Schulte H., Benker G., Hackenberg K., Reinwein D. Treatment of isolated gonadotropin deficiency in men with synthetic LR-RH and a more potent analogue of LH-RH. Neuroendocrinology. 1977;24(3-4):195–207. doi: 10.1159/000122708. [DOI] [PubMed] [Google Scholar]
  14. Wass J. A., Besser G. M., Gomez-Pan A., Scanlon M. F., Hall R., Kastin A. J., Coy D. H., Schally A. V. Comparison of long-acting analogues of luteinizing hormone releasing hormone in man. Clin Endocrinol (Oxf) 1979 Apr;10(4):419–430. doi: 10.1111/j.1365-2265.1979.tb02098.x. [DOI] [PubMed] [Google Scholar]
  15. Wiegelmann W., Solbach H. G., Kley H. K., Krüskemper H. L. LH- and FSH response to long-term application of LH-RH analogue in normal males. Horm Metab Res. 1977 Nov;9(6):521–522. doi: 10.1055/s-0028-1095583. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES